SR9009

SR9009, also known as Stenabolic, is a synthetic compound that acts as an agonist of REV-ERBα, a protein naturally present in large amounts in the liver, fat, muscle, and skeletal muscle. It works by influencing various biological mechanisms. SR9009 has been shown to reduce ischemia-induced inflammatory and oxidative damage in a Nrf2-dependent manner. It also amplifies the elimination of worn mitochondria and stimulates the generation of new ones, which can reduce inflammation and pain after strenuous exercise. Additionally, SR9009 influences the metabolism of glucose in the liver, resulting in more glucose being absorbed in the skeletal muscle instead of being stored as fat. It also increases calorie metabolism and improves the basal metabolic rate, facilitating weight loss.

SR9009 has several potential benefits. It can reduce inflammation, which can be particularly beneficial after strenuous exercise. It has been used for various medical applications, including the treatment of obesity, Type II Diabetes, sarcopenia, and cholesterol-related conditions. SR9009 can also enhance stamina, making exercise easier and more effective. It has been shown to protect against cerebral ischemic injury and improve heart function after pressure overload.

Potential side effects of SR9009 include headaches, increased water retention, liver damage, and heart damage. It has also been associated with hormonal imbalances, which can lead to various health issues like infertility, loss of muscle mass, and mood changes. Other reported side effects include insomnia and potential long-term effects such as increased cancer risk, heart attack, stroke, and mental health problems.

Due to a lack of extensive studies, it is uncertain how SR9009 might interact with other drugs or substances. As with any medication or supplement, it is important to consult with a healthcare provider before combining SR9009 with other substances to avoid potential adverse drug interactions.

The dosing guidelines for SR9009 are primarily based on anecdotal reports from bodybuilders and athletes, as there are no human trials to support specific dosages. It's estimated that about 3mg of injected Stenabolic is equivalent to 15mg of an oral dosage. However, the science supporting this is not robust, and injections carry potential side effects such as swelling or extreme pain near the injection area. For oral administration, a common starting dosage is 15mg per day, which can be increased to 20mg per day on week 5, and to 30mg per day for the last two weeks of a cycle. Due to the compound's short half-life, doses need to be split up throughout the day to maintain stable blood levels. It's important to note that the long-term effects of SR9009 are still unknown, and it has not been licensed for use in humans.

**The information provided on this post is intended solely for educational purposes and should not be considered a replacement for professional medical advice. Additionally, it is important to note that research chemicals are intended solely for laboratory study by professional researchers and are not intended for human consumption.